Bukwang Pharmaceutical Co Ltd
003000
Company Profile
Business description
Bukwang Pharmaceutical Co Ltd manufactures and markets pharmaceutical medicines. The Company's products are Dexid, Ferrova, Legaron, Thioctacid, Synthroid Latuda, Tarsenol, Orfil, Axima, Hexamedine, Dilastin Endoxan, Sirinmed, Bukwangtax, Antiplague, and others.
Contact
7 Sangdo-ro
Dongjak-Gu
Seoul
KORT: +82 28288114
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
621
Stocks News & Analysis
stocks
Chart of the Week: CGT reform strengthens the case for dividend investing
Why dividend stocks are gaining an edge after tax reform.
stocks
Finding ASX opportunities in lofty market conditions
A widening valuation gap is revealing more discounted ASX shares with moats.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,122.70 | 62.80 | -0.68% |
| CAC 40 | 8,493.10 | 84.83 | 1.01% |
| DAX 40 | 25,528.77 | 68.29 | 0.27% |
| Dow JONES (US) | 51,594.14 | 1,153.18 | -2.19% |
| FTSE 100 | 10,946.37 | 37.96 | 0.35% |
| HKSE | 25,858.88 | 50.96 | 0.20% |
| NASDAQ | 24,442.94 | 433.97 | -1.74% |
| Nikkei 225 | 61,867.43 | 433.24 | 0.71% |
| NZX 50 Index | 13,762.78 | 213.89 | -1.53% |
| S&P 500 | 7,316.15 | 112.63 | -1.52% |
| S&P/ASX 200 | 8,967.70 | 57.10 | -0.63% |
| SSE Composite Index | 3,804.69 | 23.78 | -0.62% |